Transforming growth factor-ß1 suppress pentraxin-3 in human orbital fibroblasts.
Endocrine
; 70(1): 78-84, 2020 10.
Article
en En
| MEDLINE
| ID: mdl-32300954
ABSTRACT
PURPOSE:
Transforming growth factor-ß (TGF-ß), recognized as a crucial factor in regulating fibrosis and tissue remodeling, plays a role in thyroid-associated ophthalmopathy (TAO). Pentraxin-3 (PTX3), a member of pentraxins, was recently implicated in many autoimmune and fibrotic diseases. Thus, we hypothesize if there is a potential correlation between TGF-ß and PTX3 in orbital fibroblasts (OFs).METHODS:
Several strains of OFs obtained from patients with TAO (n = 8) and healthy donors (n = 3) were established as the study model. Recombinant TGF-ß1 was exerted as an intervention and the expression of PTX3 was detected. To uncover the underlying mechanism, specific inhibitors of TGF-ß and siRNA knockdown of Smads were utilized.RESULTS:
We found that TGF-ß1 can reduce PTX3 protein expression in OFs. We also demonstrated that this downregulation was mediated at a pretranslational level, and PTX3 mRNA was inhibited in a time- and concentration-dependent manner by TGF-ß1. Interestingly, the basic level of PTX3 and the magnitude of suppression were not significantly different between TAO and control groups. Furthermore, the TGF-ß receptor complex (type Itype II) and the Smad2/3-Smad4-dependent pathway are essential for TGF-mediated PTX3 repression.CONCLUSION:
These findings indicated that TGF-ß1 can inhibit PTX3 expression in human OFs, which may participate in inflammation and fibrosis in patients with TAO and provide a potential target for the antifibrotic treatment.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Componente Amiloide P Sérico
/
Factor de Crecimiento Transformador beta1
/
Fibroblastos
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Endocrine
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2020
Tipo del documento:
Article
País de afiliación:
China